MedTrace Logo

Losartan and Memory

NCT05828940 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2023-04-27

No results posted yet for this study

Summary

This study investigates the effect of a single dose of 50mg losartan vs placebo on BOLD signal during memory encoding.

Conditions

Interventions

DRUG

Losartan Potassium

oral tablet, over-encapsulated

DRUG

Placebo

oral tablet, over-encapuslated

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Andrea Reinecke, PhD · Unoversity of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05828940 on ClinicalTrials.gov